Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

APAC Pharmaceutical Contract Manufacturing Industry Overview

The Asia Pacific pharmaceutical contract manufacturing organization market is moving towards highly fragmented market. The large pharmaceutical companies are increasingly outsourcing their production of drugs to CMOs, in order to reduce the cost of production, working capital requirement, and time to market, or to obtain a specific expertize not available in-house. This is increasing competition between vendors. Vendors are expanding across regions and are forming strategic and collaborative initiatives with companies to increase their market share and their profitability. Some of the recent developments in the market are:

• November 2019 - Jubilant Biosys announced commencement of two expansion projects in Greater Noida and Bengaluru India, owing to growing customer demand for its range of functional and integrated drug discovery services. It started design and construction of brand new and state-of-the-art chemistry services laboratories on the existing Jubilant Greater Noida site. The chemistry FTE capacity will be doubled, and operations are expected to commence from H2 2020.Thenewsitecanaccommodate upto500ChemistryFTE's.
• November 2019 - Boehringer planned a capacity expansion at its commercial manufacturing site for biologics in China. The expansion covers an addition al bioreactor an d includes all needed utility and infrastructure to support the GMP operations of 2x 2.000L single use bioreactor manufacturing lines.